NAV-003

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameNAV-003

Drug Alias NameNAV-003

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-MesothelinT-cell surface glycoprotein CD3 epsilon chain modulators

TargetsMesothelinT-cell surface glycoprotein CD3 epsilon chain

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNavrogen Inc

China Registration ClassN/A

Develop Information

Active CompaniesNavrogen Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A